Parkinson's disease and pregnancy: An updated review
- PMID: 28506531
- DOI: 10.1016/j.parkreldis.2017.05.007
Parkinson's disease and pregnancy: An updated review
Abstract
Pregnancy does not often occur in the setting of Parkinson's disease (PD) as the most common age of onset is beyond the childbearing years, yet management of these two conditions is crucial for the health of both mother and child. Here we review treatment data of PD during pregnancy, primarily from case reports and drug registries, and focus on available evidence regarding the pregnancy risks for patient and fetus. Historically, it was reported that many women had worsening of symptoms during pregnancy but this may be because anti-parkinsonian medications were not recommended or were under dosed. Levodopa has the best safety data for use in pregnancy and amantadine should be avoided in women who are pregnant or trying to become pregnant. The data for other pharmacological and surgical treatments is less clear. There is no evidence that women with PD have higher rates of birth or fetal complications.
Keywords: Levodopa; Parkinson's disease; Pregnancy; Women.
Published by Elsevier Ltd.
Similar articles
-
Current therapy of Parkinson's disease.Iowa Med. 1997 Jan;87(1):27-9. Iowa Med. 1997. PMID: 9029838 No abstract available.
-
Treatment options for early Parkinson's disease.Am Fam Physician. 1996 Mar;53(4):1281-7. Am Fam Physician. 1996. PMID: 8629572 Review.
-
Use of anti-Parkinson medication during pregnancy: a case series.J Neurol. 2018 Aug;265(8):1922-1929. doi: 10.1007/s00415-018-8937-1. Epub 2018 Jun 20. J Neurol. 2018. PMID: 29926223
-
Rationale for current therapies in Parkinson's disease.Expert Opin Pharmacother. 2003 Oct;4(10):1747-61. doi: 10.1517/14656566.4.10.1747. Expert Opin Pharmacother. 2003. PMID: 14521485 Review.
-
Parkinson's disease: managing symptoms and preserving function.Geriatrics. 1995 Sep;50(9):24-31. Geriatrics. 1995. PMID: 7672615 Review.
Cited by
-
Pregnancy in Parkinson's disease with PARK2 mutations.Clin Park Relat Disord. 2019 Aug 28;1:52-53. doi: 10.1016/j.prdoa.2019.08.003. eCollection 2019. Clin Park Relat Disord. 2019. PMID: 34316600 Free PMC article.
-
Association of women-specific health factors in the severity of Parkinson's disease.NPJ Parkinsons Dis. 2023 Jun 5;9(1):86. doi: 10.1038/s41531-023-00524-x. NPJ Parkinsons Dis. 2023. PMID: 37277346 Free PMC article.
-
Efficacy and safety of amantadine for the treatment of L-DOPA-induced dyskinesia.J Neural Transm (Vienna). 2018 Aug;125(8):1237-1250. doi: 10.1007/s00702-018-1869-1. Epub 2018 Mar 7. J Neural Transm (Vienna). 2018. PMID: 29511826 Review.
-
The first review on prenatal drug exposure and ocular malformation occurrence.Front Pediatr. 2024 Sep 4;12:1379875. doi: 10.3389/fped.2024.1379875. eCollection 2024. Front Pediatr. 2024. PMID: 39296666 Free PMC article. Review.
-
Parkinson's Disease in the Era of Personalised Medicine: One Size Does Not Fit All.Drugs Aging. 2019 Feb;36(2):103-113. doi: 10.1007/s40266-018-0624-5. Drugs Aging. 2019. PMID: 30556112
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical